Sometimes less is more.

As you look through the B section today, you’ll find the IBD 50, rather than the IBD 100.

We have analyzed the best stocks in the IBD 100 and, more important, the worst performers from this weekly feature.

Guided by our findings, we’ve tightened our selection process, focusing on the variables that separate the biggest winning stocks in any cycle from the good but not great names.

For readers, this means a list of stocks that not only is faster and easier to study, but also produces a higher batting average of success. You’ll see the very best stocks you’ve become accustomed to, without having to wade through the thinner, more volatile names.

The new IBD 50 is a concentrated watch list, worthy of careful consideration each week. Readers should never buy a stock simply because it appears on the IBD 50 or rises to the No. 1 spot.

You should always analyze the chart pattern, dig deeper into the fundamentals and read articles about the company to fully understand what sets it apart from the thousands of also-rans that populate the stock market.

As always, you’ll find a quick summary of the recent chart action and whether a leader might be nearing a potential buy point. IBD’s market writers will continue to highlight notable developments in the list each week and news about key names.

In another key change, you won’t be seeing any more boxed charts. A heavy border was IBD’s way of flagging stocks with superior fundamentals that were near buy points or in sound bases.

Since the IBD 50 is already a more focused list for readers, we’ve moved away from boxed stocks. Plus the boxes appearing on Mondays weren’t picking out some stocks that motored through buying ranges midweek.

An investor relying just on boxed stocks and ignoring other leaders could miss breakouts. Big Cap 20 and Your Weekly Review also will no longer feature stocks with borders around their charts.

Readers will still get plenty of guidance. All of the IBD 50 charts will contain timely analyses, pointing out buy points and ranges. This column will continue to focus on the best stocks, especially as they approach buy points. Be sure to read Daily Stock Analysis for a look at a leader’s fundamental and technical pros and cons. Investor’s Corner will also help you sharpen your chart reading.

In its final week, the IBD 100 lost 1.2%; the Nasdaq fell 0.5%. The NYSE rose 0.5%; the S&P 500, 0.1%.